75000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 75010 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75020 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75030 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75040 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75050 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 995455 - Disclosure - Description of Business link:presentationLink link:calculationLink link:definitionLink 995465 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 995475 - Disclosure - Reverse Recapitalization link:presentationLink link:calculationLink link:definitionLink 995485 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 995495 - Disclosure - Marketable Securities link:presentationLink link:calculationLink link:definitionLink 995505 - Disclosure - Property and Equipment, Net link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - Accrued Expenses and Other Current Liabilities link:presentationLink link:calculationLink link:definitionLink 995525 - Disclosure - License Agreement and Clinical Research Organization link:presentationLink link:calculationLink link:definitionLink 995535 - Disclosure - Notes Payable link:presentationLink link:calculationLink link:definitionLink 995545 - Disclosure - Convertible Debentures link:presentationLink link:calculationLink link:definitionLink 995555 - Disclosure - Redeemable Convertible Preferred Shares link:presentationLink link:calculationLink link:definitionLink 995565 - Disclosure - Common Shares link:presentationLink link:calculationLink link:definitionLink 995575 - Disclosure - Share-Based Compensation link:presentationLink link:calculationLink link:definitionLink 995585 - Disclosure - Net Loss Per Share link:presentationLink link:calculationLink link:definitionLink 995595 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 995605 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 995615 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 995625 - Disclosure - Segment Reporting link:presentationLink link:calculationLink link:definitionLink 995635 - Disclosure - Strategic Restructuring link:presentationLink link:calculationLink link:definitionLink 995645 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 995655 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 995665 - Disclosure - Reverse Recapitalization (Tables) link:presentationLink link:calculationLink link:definitionLink 995675 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 995685 - Disclosure - Marketable Securities (Tables) link:presentationLink link:calculationLink link:definitionLink 995695 - Disclosure - Property and Equipment, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 995705 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 995715 - Disclosure - Notes Payable (Tables) link:presentationLink link:calculationLink link:definitionLink 995725 - Disclosure - Convertible Debentures (Tables) link:presentationLink link:calculationLink link:definitionLink 995735 - Disclosure - Share-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 995745 - Disclosure - Net Loss Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 995755 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 995765 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 995775 - Disclosure - Segment Reporting (Tables) link:presentationLink link:calculationLink link:definitionLink 995785 - Disclosure - Strategic Restructuring (Tables) link:presentationLink link:calculationLink link:definitionLink 995795 - Disclosure - Description of Business - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995805 - Disclosure - Reverse Recapitalization - Summary of Net Proceeds from Reverse Recapitalization and PIPE Financing (Details) link:presentationLink link:calculationLink link:definitionLink 995815 - Disclosure - Reverse Recapitalization - Summary of Number of Common Shares Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 995825 - Disclosure - Reverse Recapitalization - Summary of Number of Common Shares Outstanding (Parenthetical) (Details) link:presentationLink link:calculationLink link:definitionLink 995835 - Disclosure - Fair Value Measurements - Schedule of Fair Value Hierarchy for Financial Assets Measured at Fair Value (Details) link:presentationLink link:calculationLink link:definitionLink 995845 - Disclosure - Fair Value Measurements - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995855 - Disclosure - Marketable Securities - Schedule of Marketable Securities (Details) link:presentationLink link:calculationLink link:definitionLink 995865 - Disclosure - Marketable Securities - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995875 - Disclosure - Property and Equipment, Net - Summary of Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 995885 - Disclosure - Property and Equipment, Net - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995895 - Disclosure - Accrued Expenses and Other Current Liabilities - Summary of Accrued Expenses and Other Current Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 995905 - Disclosure - License Agreement and Clinical Research Organization - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995905 - Disclosure - License Agreement and Clinical Research Organization - Additional Information (Details) [Default] link:presentationLink link:calculationLink link:definitionLink 995915 - Disclosure - Notes Payable - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995925 - Disclosure - Notes Payable - Schedule of Carrying Value of Term Loan (Details) link:presentationLink link:calculationLink link:definitionLink 995935 - Disclosure - Notes Payable - Schedule of Estimated Future Principal Payments Due Under the Loan Agreement (Details) link:presentationLink link:calculationLink link:definitionLink 995945 - Disclosure - Convertible Debentures - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995955 - Disclosure - Redeemable Convertible Preferred Shares - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995965 - Disclosure - Common Shares - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995975 - Disclosure - Share-Based Compensation - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995985 - Disclosure - Share-Based Compensation - Schedule of Shares Reserved For Future Issuance Under The Plan (Details) link:presentationLink link:calculationLink link:definitionLink 995995 - Disclosure - Share-Based Compensation - Schedule of Assumptions Used to Determine Grant-Date Fair Value of Stock Options (Details) link:presentationLink link:calculationLink link:definitionLink 996005 - Disclosure - Share-Based Compensation - Summary of Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 996015 - Disclosure - Share-Based Compensation - Summary of the Restricted Share Unit Activity (Details) link:presentationLink link:calculationLink link:definitionLink 996025 - Disclosure - Share-Based Compensation - Summary of Share-based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 996025 - Disclosure - Share-Based Compensation - Summary of Share-based Compensation Expense (Details) [Default] link:presentationLink link:calculationLink link:definitionLink 996035 - Disclosure - Net Loss Per Share - Summary of Basic and Diluted Net Loss Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 996045 - Disclosure - Net Loss Per Share - Summary of Basic and Diluted Net Loss Per Share (Parenthetical) (Details) link:presentationLink link:calculationLink link:definitionLink 996055 - Disclosure - Net Loss Per Share - Summary of Diluted Net Loss Per Share Attributable To Common Shareholders (Details) link:presentationLink link:calculationLink link:definitionLink 996065 - Disclosure - Income Taxes - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996075 - Disclosure - Leases - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996085 - Disclosure - Leases - Schedule of Components of Operating Lease Cost (Details) link:presentationLink link:calculationLink link:definitionLink 996095 - Disclosure - Leases - Summary of Cash Paid for Amounts Included in the Measurement of the Operating Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 996105 - Disclosure - Leases - Schedule of Maturities of Operating Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 996115 - Disclosure - Leases - Schedule of Maturities of Operating Lease Liabilities (Details) 2 link:presentationLink link:calculationLink link:definitionLink 996125 - Disclosure - Segment Reporting - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996135 - Disclosure - Segment Reporting - Summary of Significant Segment Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 996145 - Disclosure - Strategic Restructuring - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996145 - Disclosure - Strategic Restructuring - Additional Information (Details) [Default] link:presentationLink link:calculationLink link:definitionLink 996155 - Disclosure - Strategic Restructuring - Summary of Termination Benefit Expenses Recognized and Paid (Details) link:presentationLink link:calculationLink link:definitionLink 996165 - Disclosure - Subsequent Events - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink Embedded derivative liability measured at fair value Embedded Derivative, Fair Value of Embedded Derivative Liability Weighted average expected life (in years) Warrants, contractual term Warrants exercisable period Aggregate amount of shares exchanged Convertible Preferred Stock, Shares Issued upon Conversion Long Term Marketable Securities [Member] Long term marketable securities Long Term Marketable Securities Interest expense, including the amortization of debt discounts Interest Expense Including Amortization Of Debt Discounts Interest expense including amortization of debt discounts. Cash dividend paid Common Stock, Dividends, Per Share, Cash Paid Restructuring and Related Activities Disclosure [Text Block] Strategic Restructuring Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions Number of unrealized loss position One-time Termination Benefits [Member] Employee Termination Benefit Expense One-time payment for milestone product Milestone Product Payment Milestone product payment Common stock shares reserved for future issuance Aggregate number of common shares reserved for future issuance Common Stock, Capital Shares Reserved for Future Issuance Summary of Accrued Expenses and Other Current Liabilities Schedule of Accrued Liabilities [Table Text Block] Preferred stock shares issued Preferred Stock, Shares Issued Notes Payable Debt Disclosure [Text Block] Operating Lease, Liability, Total Operating lease liabilities Operating Lease, Liability Total Lease liability Initial annual base rent Initial Annual Base Rent Per Square Foot Initial annual base rent per square foot. Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total Unrecognized compensation expense Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Temporary equity shares authorized Temporary Equity, Shares Authorized Long-Term Line of Credit Long-Term Line of Credit, Total Term loan Long-Term Debt, Maturity, Year Three 2028 Debt instrument, basis spread on variable rate Term loan annual interest rate Debt Instrument, Basis Spread on Variable Rate Weighted-average number of common shares used in net loss per share, diluted Weighted Average Number of Shares Outstanding, Diluted, Total Weighted-average common shares outstanding, diluted Weighted Average Number of Shares Outstanding, Diluted General and administrative expenses: General and Administrative Expense [Abstract] Operating lease initial term Lessee, Operating Lease, Term of Contract Minimum Minimum [Member] Minimum [Member] Long-Term Debt, Maturity, Year Two 2027 Effective interest rate of outstanding debt Debt Instrument, Interest Rate, Effective Percentage Interest rate Preferred stock shares outstanding Preferred Stock, Shares Outstanding, Beginning Balance Preferred Stock, Shares Outstanding, Ending Balance Preferred Stock, Shares Outstanding May 2023 Notes May Two Thousand Twenty Three Notes [Member] May two thousand twenty three notes. Fair Value Measurement Recurring Fair Value, Recurring [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Vesting percentage Common stock shares issued Common Stock, Shares, Issued Segment Reporting [Line Items] Applied to Refinance of Amount Outstanding Applied to Refinance of Amount Outstanding [Member] Applied to refinance of amount outstanding. Principal amount Term loans aggregate principal amount Borrowed amount Options vested and exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Total income tax expense (benefit) Income Tax Expense (Benefit) Income tax benefit (expense) Income tax expense (benefit) Provision for income taxes Manufacturing Payment Fee Manufacturing payment fee. Fee related to the manufacturing payment Reverse recapitalization embedded derivative fair value of embedded derivative Reverse Recapitalization Embedded Derivative Fair Value Of Embedded Derivative Reverse recapitalization embedded derivative fair value of embedded derivative. Counterparty Name [Domain] Debt Securities Unrealized Losses Debt securities unrealized losses. Debt securities unrealized losses Restricted Stock Units (RSUs) [Member] Restricted share units Area of space. Area of office space Rentable square feet Area Of Space Class B-1 Redeemable Convertible Preferred Shares Class B-1 Redeemable Convertible Preferred Shares [Member] Class b-1 redeemable convertible preferred shares. Share warrants issued Number of securities into which the class of warrant or right may be converted Warrant issued to purchase preferred shares Percentage of prepayment premium of principal amount outstanding of the closing date Percentage of Prepayment Premium of Principal Amount Outstanding of the Closing Date Percentage of prepayment premium of principal amount outstanding of the closing date. Assets transfers or reclassifications out of level 3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 Asset, Impairment Loss Asset Impairment Charges, Total Loss on impairment of assets Line of credit, maximum amount available Term loan facility aggregate principal amount Line of Credit Facility, Maximum Borrowing Capacity Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than OptionsGrants In Period Related to Performance Based Retention Awards, Weighted Average Grant Date Fair Value Share based compensation arrangement by share based payment award equity instruments other than options grants In period related to performance based retention awards, weighted average grant date fair value. Granted - performance-based retention share units (June 2026) Accrued Income Taxes, Current Income taxes payable Amortized Cost Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost Subsequent Event Type [Domain] Temporary equity aggregate amount of redemption requirement Temporary Equity, Aggregate Amount of Redemption Requirement Old enGene Shareholders (Excluding Convertible Notes) Old EnGene Shareholders [Member] Old EnGene shareholders. Lessee, Operating Lease, Liability, Undiscounted Excess Amount Less: Interest Property and Equipment, Net Property, Plant, and Equipment [Text Block] April 2023 Notes April Two Zero Two Three Notes [Member] April two zero two three notes. Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Effect of exchange rate changes on cash and cash equivalents Total other (income) expense, net Nonoperating Income (Expense) Total other income, net Other Research and Development Expenses Other Research and Development Expenses [Member] Other research and development expenses. Schedule of Long-Term Debt Instruments [Table] Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum Maximum percentage of outstanding common shares owned by the holder Investment tax credit receivable Investment tax credit receivable Increase (Decrease) In Investment Tax Credit Receivable Increase (decrease) in investment tax credit receivable. General and Administrative Expense, Total General and administrative General and Administrative Expense Total general and administrative expenses Income Statement [Abstract] Common Stock Outstanding After Reverse Recapitalization and PIPE Financing Total Common Shares outstanding immediately after the Reverse Recapitalization and PIPE Financing Common stock outstanding after reverse recapitalization and pipe financing. FEAC Shareholders, including sponsor's and shareholder with non-redemption agreement FEAC Shareholders [Member] FEAC shareholders. Advance Subject to Achievement of Specified Interim Milestone [Member] Advance subject to achievement of specified interim milestone. Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Forfeited or expired Debt discount, net of accretion Debt Instrument, Unamortized Discount, Total Debt Instrument, Unamortized Discount Performance-based Non-qualified Stock Options Awards Issued Performance-based non-qualified stock options awards issued. Performance-based non-qualified stock options awards issued Restricted investments Restricted Investments Schedule of Components of Operating Lease Cost Lease, Cost [Table Text Block] Fair value debt inputs measurement input Debt Instrument, Measurement Input Class A Redeemable Convertible Preferred Shares Class A Redeemable Convertible Preferred Shares [Member] Class a redeemable convertible preferred shares. Warrant To Purchase Common Stock [Member] Warrant To Purchase Common Stock. Warrants to purchase common shares Vesting [Axis] Class B Redeemable Convertible Preferred Shares Class B Redeemable Convertible Preferred Shares [Member] Class b redeemable convertible preferred shares. Earnings Per Share, Basic, Total Net loss per share of common shares, basic Earnings Per Share, Basic Net loss per share of common shares, basic Period End Date Document Period End Date License Agreement [Table] License Agreement Table Accrued Expenses and Other Current Liabilities Accounts Payable and Accrued Liabilities Disclosure [Text Block] Convertible Notes Payable, Total Convertible notes net Convertible Notes Payable Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment, Total Payments to Acquire Property, Plant, and Equipment Debt Instrument [Line Items] Weighted-Average Exercise Price, Granted Exercise price Exercise price Aggregate sale of convertible promissory notes, warrants, preferred shares, common shares, or combined thereof Aggregate Sale Of Convertible Promissory Notes Warrants Preferred Shares Common Shares Or Combined Thereof Aggregate sale of convertible promissory notes warrants preferred shares common shares or combined thereof. Convertible Debentures Embedded Derivative Liabilities Embedded Derivative Financial Instruments [Member] Statement of Stockholders' Equity [Abstract] Description of Business [Line Items] Description of business. Prepaid and other current assets Prepaid Expense and Other Assets, Current Stock options vesting service period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period Foreign Currency Transactions and Translations Policy [Policy Text Block] Foreign Currency Entity Address, Country Other Comprehensive Income (Loss), Tax [Abstract] Other comprehensive loss (income): 2022 Notes and BDC Notes Convertible Debentures Embedded Derivative Liabilities for 2022 Notes and BDC Notes [Member] Convertible debentures embedded derivative liabilities for 2022 notes and BDC notes Maximum Amount Of Common Shares To Be Sold Maximum amount of common shares to be sold. Maximum amount of common shares to be sold Interest rate Debt Instrument, Interest Rate, Stated Percentage Accrue interest rate percentage Annual maintenance fee Cost, Maintenance Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Aggregate Intrinsic Value, Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Exercise price equal to percentage of aggregate amount of term loans Percentage of Aggregate Term Loan Funded Percentage of aggregate term loan funded. Advance Subject To Achievement Of Specified Commercial Milestone [Member] Advance subject to the achievement of the specified Commercial Milestone. Advance Subject to Achievement of Specified Commercial Milestone Common stock no par value Common Stock, No Par Value Percentage of common stock value on date of grant Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Total assets Assets Prior loan agreement. Prior Loan Agreement [Member] Prior Loan Agreement Title of 12(b) Security Tranche Two Tranche Two [Member] Tranche two. Goodwill, Total Goodwill, Beginning Balance Goodwill, Ending Balance Goodwill Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Number of shares outstanding, Ending balance Number of shares outstanding, Beginning balance Exercise of stock options Stock Issued During Period, Value, Stock Options Exercised Summary of Share-based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Shares Granted Granted Number of stock option award issued during the period Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent, Total Unrealized gain on available-for-sale investments Unrealized loss (gain) on available-for-sale investments Operating Lease, Payments Cash paid for amounts included in the measurement of operating lease liabilities Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Summary of Restricted Share Unit Activity Antidilutive Securities, Name [Domain] Share exchange ratio Stockholders' Equity Note, Stock Split, Conversion Ratio Variable Rate [Axis] 2026 Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activity Intangible Assets, Gross (Excluding Goodwill), Total Intangible assets Intangible Asset, Excluding Goodwill, before Accumulated Amortization Lessee, Operating Lease, Liability, to be Paid, Year One 2027 Aggregate Intrinsic Value, Options unvested Share Based Compensation Arrangement By Share Based Payment Award Options Unvested Aggregate Intrinsic Value Share based compensation arrangement by share based payment award options unvested aggregate intrinsic value. Weighted- Average Remaining Contractual Term (in years), Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted-Average Remaining Contractual Term Summary of Significant Segment Expenses Segment Reporting [Table Text Block] Increase (Decrease) in Operating Lease Liability Lease liabilities Cash Cash Leases Lessee, Operating Leases [Text Block] Fair value of common shares and exercise price of options Share Based Compensation Arrangement By Share Based Payment Award Fair Value of Common Shares and Exercise Price of Options Share based compensation arrangement by share based payment award fair value of common shares and exercise price of options. Reverse Recapitalization Reverse Recapitalization TextBlock Reverse Recapitalization TextBlock Beginning balance Ending balance Equity, Attributable to Parent Total shareholder's equity Class C Warrants Class C Warrants [Member] Class C Warrants. Other assets Other Assets, Noncurrent Collaborative Arrangement and Arrangement Other than Collaborative [Domain] First Amendment to Amended and Restated Loan and Security Agreement [Member] First amendment to amended and restated loan and security agreement. Income Taxes Income Tax Disclosure [Text Block] Summary of Change in Estimated Fair Value of Liabilities Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Table Text Block] Accrued interest receivable Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss, Total Net Loss Per Share Earnings Per Share [Text Block] Total aggregate proceeds Proceeds from Issuance of Redeemable Convertible Preferred Stock Amended Loan Agreement Amended Loan Agreement [Member] Amended loan agreement. First Amended Loan Agreement Reverse Recapitalization [Line Items] Reverse recapitalization. May 2023 Notes May Twenty Twenty Three Notes [Member] May Twenty Twenty Three Notes. Number of Reportable Segments Number of Reportable Segments Prefunded Warrant [Member] Pre-funded warrant. Pre-funded warrants Stockholders' Equity Note [Abstract] Expiring term of warrants Class of Warrant or Right, Date from which Warrants or Rights Exercisable Cash - FEAC's Trust Account and Cash (net of redemptions and cash paid for FEAC expenses prior to close) Proceeds from trust account Proceeds From Trust Account Proceeds from trust account. Notes Payable, Noncurrent, Total Note payable, net of current portion Notes Payable, Noncurrent Schedule of Fair Value Hierarchy for Financial Liabilities Measured at Fair Value Fair Value, Liabilities Measured on Recurring Basis [Table Text Block] Long-Term Debt Note payable, net of discount Credit Facility [Axis] Preferred share warrants fair value Preferred Share Warrants Fair Value Preferred share warrants fair value. Stock, Class of Stock [Table] Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Unrealized Gains End of term charge End of Term Charge End of term charge. Warrants exercisable period Class Of Warrant Or Right Year From Which Warrants Or Rights Exercisable Class of warrant or right year from which warrants or rights exercisable. Wall Street Journal Wall Street Journal [Member] Wall street journal. Settlement upon the consummation of the Reverse Recapitalization Repayment of convertible debentures Repayment of aggregate amount Repayment of convertible debentures Repayments of Convertible Debt Tranche One. Tranche One [Member] Tranche One Proceeds from Stock Options Exercised Proceeds from exercise of stock options Aggregate gross proceeds from option exercise Short-term operating lease cost Short-Term Lease, Cost Percentage of aggregate principal amount of term loan advance to purchase number of common shares Percentage Of Aggregate Principal Amount Of Term Loan Advance To Purchase Number Of Common Shares Percentage of aggregate principal amount of term loan advance to purchase number of common shares. Convertible Notes - Common Shares issued Convertible Notes Convertible Notes [Member] Convertible notes. Geographical [Domain] Warrants, maturity date Warrants and Rights Outstanding, Maturity Date Non-cash Stock-based Compensation Expense, Vesting Of Performance-based Equity Retention Awards Non-cash stock-based compensation expense, vesting of performance-based equity retention awards. Non-cash stock-based compensation expense, vesting of performance-based equity retention awards Schedule of Estimated Future Principal Payments Due Under the Loan Agreement Schedule of Maturities of Long-Term Debt [Table Text Block] Statistical Measurement [Axis] Operating lease commencement period Operating Lease Commencement Period Operating lease commencement period. Money Market Funds Money Market Funds [Member] Preferred stock no par value Preferred Stock, No Par Value Entity Interactive Data Current Restructuring and Related Costs [Table Text Block] Summary of Termination Benefit Expenses Recognized and Paid Expected volatility, Maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Loss on extinguishment of convertible debentures Gain (Loss) on Extinguishment of Debt, Total Loss on extinguishment of convertible debentures Gain (Loss) on Extinguishment of Debt Gain on extinguishment of debt Loss on extinguishment of debt Loss on extinguishment of debt Lessee, Operating Lease, Liability, to be Paid, Year Three 2029 Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items] Weighted- Average Remaining Contractual Term (in years), Options vested and exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Common Stock, Value, Issued Common shares, no par value; unlimited shares authorized, 67,014,067 and 52,018,658 shares issued and outstanding as of July 31, 2026 and October 31, 2025, respectively. Fair Value, off-Balance-Sheet Risk [Table] Summary of Basic and Diluted Net Loss Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Government Agency Securities [Member] US Government Agencies Debt Securities [Member] Government Agency Securities Redeemable Convertible Preferred Shares Preferred Stock [Text Block] Description of Business Business Description and Basis of Presentation [Text Block] Term loan reduced annual interest rate Debt Instrument, Interest Rate, Increase (Decrease) Warrant value issued as part of Second Amended Term Loan Warrant Value Issued as Part of Second Amended Term Loan Warrant value issued as part of second amended term loan. Liabilities, Total Total liabilities Liabilities Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net, Total Debt discount and issuance costs Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Lessee operating lease liability payments due after year four. Lessee Operating Lease Liability Payments Due After Year Four Thereafter Accumulated deficit Retained Earnings (Accumulated Deficit), Total Accumulated deficit Retained Earnings (Accumulated Deficit) Total commitment amount Commitment Amount Commitment amount. Level 3 Fair Value, Inputs, Level 3 [Member] Other Nonoperating Income (Expense) [Abstract] Other expenses (income), net: Price per unit paid for common shares and warrants Price Per Unit Paid for Common Shares and Warrants Price per unit paid for common shares and warrants. Cash and Cash Equivalents, Fair Value Disclosure Cash equivalents Accounts payable Increase (Decrease) in Accounts Payable, Total Increase (Decrease) in Accounts Payable Total operating expenses Operating Expenses Cash dividends declared Common Stock, Dividends, Per Share, Declared Fair value of shares Share Price Share price Vesting [Domain] Percentage of increase in annual base rent Percentage of Increase in Annual Base Rent Percentage of increase in annual base rent. Accrued interest Debt Instrument, Accrued Interest Debt instrument, accrued interest. Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Shares issued, price per share Shares Issued, Price Per Share Number of new stock issued during the period Stock Issued During Period, Shares, New Issues Issuance of common shares Lease Cost: Lease, Cost [Abstract] Marketable Security, Unrealized Gain (Loss) Unrealized (gain) loss on marketable securities Warrants outstanding Class of Warrant or Right, Outstanding Variable Rate [Domain] Class A Initial Closing Class A Initial Closing [Member] Class A initial closing. Risk-free interest rate, Maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Redeemable convertible preferred shares value Beginning balance Ending balance Temporary Equity, Carrying Amount, Attributable to Parent Summary of Net Proceeds from Reverse Recapitalization and PIPE Financing Summary of Net Proceeds from Reverse Recapitalization and PIPE Financing [Table Text Block] Summary of net proceeds from reverse recapitalization and pipe financing. Financial liabilities, fair value Financial Liabilities Fair Value Disclosure, Total Financial liabilities Financial Liabilities Fair Value Disclosure Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total Less: Accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance Property, Plant, and Equipment, Accumulated Depreciation, Depletion, and Amortization Weighted-Average Exercise Price, Forfeited or expired Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Operating lease cost Operating Lease, Cost Long-Lived Asset, Class [Axis] Subsequent Events Subsequent Events [Text Block] Other General and Administrative Expense Other general and administrative expenses Fair Value Hierarchy and NAV [Axis] Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Transfers or reclassifications into level 3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 Series 1 Class C Redeemable Convertible Preferred Series 1 Class C Redeemable Convertible Preferred [Member] Series 1 class c redeemable convertible preferred. Property, Plant, and Equipment [Line Items] Property, Plant and Equipment [Line Items] Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Term Loan Term Loan [Member] Term loan. Aggregate Fair Value Debt Securities, Available-for-Sale Debt Securities, Available-for-Sale, Total Payments of Stock Issuance Costs Payment of issuance cost associated with public offering and pre-funded warrants Payment of issuance cost associated with public offering and pre-funded warrants Operating Lease, Liability, Current Operating lease liabilities, current Inducement Grants Inducement Grants [Member] Inducement Grants [Member] Operating lease, option to extend Lessee, Operating Lease, Existence of Option to Extend [true false] 2023 Plan Two Zero Two Three Plan [Member] Two zero two three plan. Schedule of Significant Segment Expenses, Other Segment Items and Measure of Segment Net Loss [Table Text Block] Schedule of significant segment expenses, other segment items and measure of segment net loss. Summary of Significant Segment Expenses Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Weighted- Average Grate Date Fair Value Outstanding Beginning balance Weighted- Average Grate Date Fair Value Outstanding Ending balance Liabilities and Equity Total liabilities and shareholders' equity Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Weighted- Average Remaining Contractual Term (in years), Options unvested Share Based Compensation Arrangement By Share Based Payment Award Options Unvested Weighted Average Remaining Contractual Term1 Share based compensation arrangement by share based payment award options unvested weighted average remaining contractual term1. Lessee, Operating Lease, Liability, to be Paid, Year Two 2028 Research and Development Expense, Total Research and development Research and Development Expense Total research and development expenses Office Space Office space. Office Space [Member] Lessee, Lease, Description [Table] Document Fiscal Period Focus Schedule of Assumptions Used to Determine Grant-Date Fair Value of Stock Options Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Summary of Loss Before Provision for Income Taxes Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] License Agreement and Clinical Research Organization [Line Items] License agreement and clinical research organization line items. Property, Plant, and Equipment [Table] Uncommitted Tranche [Member] Uncommitted Tranche Uncommitted Tranche Proceeds from issuance of pre-funded warrants Proceeds from Issuance of Warrants Canada CANADA Sale of Stock [Axis] Less transaction costs withheld from cash proceeds on Closing Date Transaction Cost Withheld From Proceeds Received Transaction cost withheld from rroceeds received. Tranche 3 Advance Tranche Three Advance [Member] Tranche three advance. Note payable current Notes Payable, Current, Total Notes Payable, Current Current portion of note payable Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Net decrease in cash and cash equivalents Entity Current Reporting Status 2023 Financing Two Zero Two Three Financing Member Two Zero Two Three Financing. Use of Estimates, Policy [Policy Text Block] Use of Estimates Performance-Based Equity Retention Awards [Member] Performance-Based Equity Retention Awards Member. Performance-Based Equity Retention Awards Level 1 Fair Value, Inputs, Level 1 [Member] Class of Stock [Domain] Accounts Payable, Current, Total Accounts payable Accounts Payable, Current Summary of Shares Excluded from Computation of Diluted Net Loss Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Financial Instrument [Axis] Financial assets, fair value Assets, Fair Value Disclosure Total financial assets Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss, Statement of Financial Position [Extensible Enumeration] Weighted-Average Exercise Price, Options unvested Exercise price Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price, Beginning Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price, Ending Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price Document Transition Report Restructuring and Related Cost, Expected Cost Restructuring and Related Cost, Expected Cost, Total Estimated restructuring costs Rule10 B51 Trading Plan [Member] Rule10 b51 trading plan. Rule10 B51 Trading Plan Lessee Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Preferred stock shares authorized unlimited Preferred Stock, Shares Authorized, Unlimited [Fixed List] Subsequent Event [Line Items] Transfers or reclassifications out of level 3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 Class of Warrant or Right [Axis] Forbion Growth Sponsor FEAC I B.V Forbion Growth Sponsor FEAC I B.V [Member] Forbion Growth Sponsor FEAC I B.V Member. Current liabilities: Liabilities, Current [Abstract] Share-Based Payment Arrangement [Abstract] Underwritten Public Offering [Member] Underwritten public offering. Earnings Per Share [Line items] Earnings Per Share Common stock issued redemption price Common Stock Issued Redemption Price Common stock issued redemption price. Common Shares Common Stock [Member] Proceeds from Lines of Credit, Total Proceeds from line of credit Proceeds from Lines of Credit Credit Facility [Domain] Statistical Measurement [Domain] Class C Second Tranche Class C Second Tranche [Member] Class c second tranche. Class C Redeemable Convertible Preferred Shares Class C Redeemable Convertible Preferred Shares [Member] Class C redeemable convertible preferred shares. Long-Lived Asset, Excluding Financial Instrument, Customer Relationship, Mortgage Servicing Right, Deferred Policy Acquisition Cost, and Deferred Tax Asset, Amount Long-lived assets Employee Severance [Member] Employee Severance Equity, Attributable to Parent [Abstract] Shareholder's equity: Weighted-average number of common shares used in net loss per share, basic Weighted Average Number of Shares Outstanding, Basic, Total Weighted-average common shares outstanding, basic Weighted Average Number of Shares Outstanding, Basic Property, Plant and Equipment [Abstract] Assets Assets [Abstract] Series 4 Class C Redeemable Convertible Preferred Series 4 Class C Redeemable Convertible Preferred [Member] Series 4 class c redeemable convertible preferred. Entity Central Index Key CIK US Treasury and Government [Member] Restructuring Charges Restructuring Charges, Total Employee termination benefit expense incurred during the period Restructuring charges Antidilutive Securities [Axis] Class of Stock [Line Items] Current Fiscal Year End Date Class of Warrant or Right [Domain] Document Quarterly Report Term loan maturity date Maturity date Debt Instrument, Maturity Date Net loss attributable to common stockholders, diluted Net loss attributable to common shareholders, diluted Net Income (Loss) Available to Common Stockholders, Diluted, Total Net loss attributable to common stockholders, diluted Net Income (Loss) Available to Common Stockholders, Diluted Lease expiration date Lease Expiration Date Level 2 Fair Value, Inputs, Level 2 [Member] Exercise price Weighted-Average Exercise Price Outstanding, Beginning balance Weighted-Average Exercise Price Outstanding, Ending balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Cash flows from operating activities Net cash used in operating activities Cash flows from operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Entity Incorporation, State or Country Code Earnings Per Share, Diluted, Total Net loss per share of common shares, diluted Earnings Per Share, Diluted Net loss per share of common shares, diluted Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period Shares issued Initial aggregate amount that company agreed to sell Sale of Stock, Number of Shares Issued in Transaction Cash proceeds received from the Reverse Recapitalization and PIPE Financing on Closing Date Gross Cash Proceeds Received from Reverse Recapitalization and Pipe Financing Gross cash proceeds received from reverse recapitalization and pipe financing. Net loss Net loss Net loss Net loss Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Long-Lived Asset, Class [Domain] Lease Expiration Month and Year Lease expiration month and year. Lease expiration month and year Interim Period, Costs Not Allocable [Domain] Type of Restructuring [Domain] Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent, Total Other comprehensive income (loss) Shares issued in exchange of debt instrument Debt Conversion, Converted Instrument, Shares Issued Series 3 class c redeemable convertible preferred. Series 3 Class C Redeemable Convertible Preferred Series 3 Class C Redeemable Convertible Preferred [Member] Anthony Cheung [Member] Anthony cheung. Anthony Cheung Total comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Total comprehensive loss If Interim Milestone Achieved and No Default If Interim Milestone Achieved and No Default [Member] If interim milestone achieved and no default. Measurement Frequency [Domain] Remaining shares reserved for future issuance under ESSP Remaining shares reserved for future issuance under ESSP [Member] Remaining shares reserved for future issuance under ESSP. Debt Instrument, Fair Value Disclosure, Total Fair value of debt instrument Debt Instrument, Fair Value Disclosure Equity Components [Axis] Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Cash flows from investing activities Statement of Cash Flows [Abstract] Fair Value Hierarchy and NAV [Domain] Income Tax Disclosure [Abstract] Weighted-Average Exercise Price, Exercised Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted-average grant-date fair value per share of share options granted Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss Aggregate fair value Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets End of term fee percentage End of Term Fee Percentage End of term fee percentage. Accrued interest percentage Debt Instrument Accrued Interest Rate Debt instrument accrued interest rate. Fair Value Measurements Fair Value Disclosures [Text Block] Depreciation, Depletion and Amortization, Total Depreciation and amortization expense Depreciation, Depletion and Amortization Estimated Recognition of Non-cash Stock-based Compensation Expense Upon Vesting of Milestone Estimated recognition of non-cash stock-based compensation expense upon vesting of milestone. Estimated recognition of non-cash stock-based compensation expense upon vesting of milestone April 2023 Notes April Twenty Twenty Three Notes [Member] April Twenty Twenty Three Notes Member. May 2023 Notes May Two Thousand Two Three Notes Member May Two Thousand Two Three Notes. Reverse recapitalization price per unit paid common shares and warrants Reverse Recapitalization Price Per Unit Paid Common Shares And Warrants Reverse recapitalization price per unit paid common shares and warrants. Derivative Contract [Domain] Class of Stock [Axis] Shares excluded from computation of diluted net loss per share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Counterparty Name [Axis] Class C Inital Closing Class C Initial Closing [Member] Class C initial closing. Measurement Input, Expected Term Measurement Input, Expected Term [Member] Expected time to respective scenarios Number of Operating Segments Number of Operating Segments Class C Preferred Shares Series C Preferred Stock [Member] Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Class B Intial Closing Class B Initial Closing [Member] Class B initial closing. Temporary Equity, Shares Outstanding Temporary equity shares outstanding Beginning balance (in shares) Ending balance (in shares) Share Based Compensation Arrangement by Share Based Payment Award Equity Instruments Other Than Options Granted Related to Performance Based Retention Awards Share based compensation arrangement by share based payment award equity instruments other than options granted related to performance based retention awards. Granted - performance-based retention share units (June 2026) Amended Employment Agreement Amended Employment Agreement [Member] Amended Employment Agreement. License Agreement and Clinical Research Organization [Abstract] License Agreement and Clinical Research Organization Summary of Number of Common Shares Outstanding Schedule of Common Stock Outstanding Roll Forward [Table Text Block] BDC Notes BDC Notes [Member] BDC Notes Member. Common stock shares authorized unlimited Common Stock, Shares Authorized, Unlimited [Fixed List] Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Accrued expenses and other current liabilities Percentage of principal Percentage Of Principal Amount Percentage Of Principal Amount. Repayments of term loan principal Repayments of term loan principal. Repayment of Amended Term Loan principal Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Pre-funded warrants to purchase common shares Pre-Funded Warrants to Purchase Common Shares [Member] Pre-Funded Warrants to Purchase Common Shares. Number of shares outstanding, Beginning balance Number of shares outstanding, Ending balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Long-Term Debt, Maturity, Year Five 2030 Number of Securities Held Number of securities held. Number of securities held Short-Term Debt [Line Items] Short-Term Debt [Table] Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Unrealized Losses Options unvested Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares, Beginning Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares, Ending Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares Document Type Document Type Percentage of prepayment premium of principal amount outstanding prior to twenty-four months Percentage of Prepayment Premium of Principal Amount Outstanding Prior to Twenty Four Months Percentage of prepayment premium of principal amount outstanding prior to twenty four months. Cash Flows from operating activities: Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Class A Second Tranche Class A Second Tranche [Member] Class a second tranche. Liabilities and Equity [Abstract] Liabilities and shareholders' equity Estimated Non-cash Stock-based Compensation Expense Estimated non-cash stock-based compensation expense. Estimated non-cash stock-based compensation expense Estimated non-cash stock-based compensation expense incurred Forfeited or expired Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Total Forfeited or expired Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Lessee, Lease, Description [Line Items] Options to purchase common shares Schedule of Shares Reserved for Future Issuance Under the Plan Schedule of Shares Reserved For Future Issuance Under The Plan Table Text Block Schedule of shares reserved for future issuance under the plan. Subsequent Event Subsequent Event [Member] Loss from operations Operating Income (Loss) Operating Income (Loss), Total Loss from operations Estimated Payment of Aggregate Cash Retention Bonus Awards Estimated payment of aggregate cash retention bonus awards. Estimated payment of aggregate cash retention bonus awards Net cash proceeds from the Reverse Recapitalization and PIPE Financing Net Cash Proceeds Received from Reverse Recapitalization and Pipe Financing. Net cash proceeds received from reverse recapitalization and pipe financing. Redeemable convertible preferred shares at a price per share Sale of Stock, Price Per Share Common share price per share Lender Name [Axis] Proceeds from public offering Proceeds from Public Offering Proceeds from public offering. Short Term Marketable Securities [Member] Short term marketable securities Short Term Marketable Securities Segment Reporting [Table] Income Tax Contingency [Line Items] Asset Class [Domain] Entity File Number Accrued interest receivable written off Accrued Interest Receivable Written Off Accrued interest receivable written off. If Interim Milestone and Certain Clinical Milestones Achieved and No Default If Interim Milestone and Certain Clinical Milestones Achieved and No Default [Member] If interim milestone and certain clinical milestones achieved and no default. Rule10 B51 Trading Plan One [Member] Rule10 b51 trading plan one Shares Acquired Eexercise of Stock Options Total accrued expenses and other current liabilities Accrued expenses and other current liabilities Accrued Liabilities and Other Liabilities Lab Equipment Equipment [Member] Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Schedule of Maturities of Operating Lease Liabilities Location, Statement of Income, Balance [Axis] Risk-free interest rate, Minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Accumulated Deficit Retained Earnings [Member] Probability of Qualified Financing Measurement Input Probability Of Qualified Financing [Member] Measurement input probability of qualified financing. Reverse Recapitalization [Table] Reverse recapitalization. Marketable Securities Investment in Debt and Equity Securities and Other Trading Assets [Text Block] Registrant Name Entity Registrant Name Restructuring Reserve Restructuring Reserve, Total Accrued employee termination benefits beginning balance Accrued employee termination benefits as of period end Accounting Policies [Abstract] Depreciation, Total Depreciation of property and equipment Depreciation Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Preferred Share Warrant Liabilities Preferred Share Warrant Liabillities [Member] Preferred share warrant liabilities. Proceeds from Issuance of Debt Proceeds from Second Amended Term Loan Operating lease renewal term Lessee, Operating Lease, Renewal Term Payment-in-kind interest rate Paid-in-kind Interest Percentage Paid-in-kind interest percentage. Phase II Clinical Trial Phase II Clinical Trial [Member] Entity Address, Address Line One Percentage of Outstanding Common Shares Owned by The Holder Percentage of outstanding common shares owned by the holder. Percentage of outstanding common shares owned by the holder Advance Subject to Achievement of Specified Clinical Milestone [Member] Advance subject to achievement of the Clinical Milestone. Advance Subject to Achievement of Specified Clinical Milestone Line of credit, maturity date Line of Credit Facility, Expiration Date United States UNITED STATES Redeemable convertible preferred shares Redeemable Convertible Preferred Stock [Member] Exercised Exercised Exercise of stock options (in shares) Stock options exercised Investment tax credits receivable Investment Tax Credits Receivable Investment tax credits receivable. Restructuring Cost [Table] Cash - PIPE Financing Proceeds from Issuance or Sale of Equity, Total Proceeds from PIPE financing Proceeds from Issuance or Sale of Equity Notes purchase principal amount Debt Instrument, Issued, Principal Total current assets Assets, Current Total current assets Office Furniture Furniture and Fixtures [Member] Common stock voting rights Common Stock, Voting Rights Aggregate number of common shares outstanding percentage Common Shares Percentage Common shares percentage. Fair Value, Recurring and Nonrecurring [Table] Entity Listings [Line Items] Tranche three advance subject to achievement of specified interim milestone Tranche Three Advance Subject To Achievement Of Specified Interim Milestone [Member] Tranche three advance subject to achievement of specified interim milestone. Shares Reserved For Future Issuance Under the Two Thousand and Twenty Three Plan [Member] Shares reserved for future issuance under the two thousand and twenty three plan [Member] Remaining shares reserved for future issuance under the 2023 Plan Nature of Expense [Axis] Operating lease extended term Lessee, Operating Lease, Extended Term Lessee, operating lease, extended term. Supplemental cash flow information: Supplemental Cash Flow Information [Abstract] Entity Small Business Aggregate Intrinsic Value, Options vested and exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Restructuring and Related Cost, Cost Incurred to Date Second Amended Loan Agreement [Member] Second Amended Loan Agreement. Second Amended Loan Agreement Personnel-Related Expenses Excluding Stock-Based Compensation [Member] Personnel-related expenses, excluding stock-based compensation. Personnel-Related Expenses Excluding Stock-Based Compensation Office and Lab Space Office and Lab Space [Member] Office and lab space. Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Forfeited or expired Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale, Total Proceeds from maturities of marketable securities Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Employee compensation and related benefits Employee-related Liabilities, Current, Total Employee-related Liabilities, Current Old hercules warrants. Old Hercules Warrants [Member] Old Hercules Warrants Share-Based Compensation Arrangement by Share-Based Payment Award, Options Expired Share-based compensation arrangement by share-based payment award, options expired. Stock option expired Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Restructuring and Related Activities [Abstract] Payment of Financing and Stock Issuance Costs Payment of Financing and Stock Issuance Costs, Total Underwriting discounts and commissions and offering expenses Earnings Per Share [Abstract] Summary of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Inducement Grant Stock Options Awarded Outside The Two Thousand and Twenty Three Plan [Member] Inducement grant stock options awarded outside the two thousand and twenty three plan. Inducement grant stock options awarded outside of the 2023 Plan Lessee, Operating Lease, Liability, to be Paid, Year Four 2030 Common stock capital shares reserved for remaining future issuance Common Stock Capital Shares Reserved for Remaining Future Issuance Common stock capital shares reserved for remaining future issuance. Plan Name [Axis] Subsequent Event Type [Axis] Equity [Abstract] Proceeds from issuance of April 2023 Notes Proceeds from convertible debt Proceeds from Convertible Debt Common Shares Equity [Text Block] Repayments of convertible notes and warrants Repayments Of Convertible Notes and Warrants Repayments of convertible notes and warrants. Percentage of facility charge on amount borrowed Percentage of Facility Charge on Amount Borrowed Percentage of facility charge on amount borrowed. Measurement Frequency [Axis] Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Cash flows from financing activities Amortization of debt discount Amortization of Debt Discount (Premium) Accrued Research And Development Expense Current Accrued research and development expenses current. Research and development expenses Percentage of prepayment premium of principal amount outstanding prior to maturity date Percentage of Prepayment Premium of Principal Amount Outstanding Prior to Maturity Date Percentage of prepayment premium of principal amount outstanding prior to maturity date. Repayment Debt Instrument, Repaid, Principal Line of Credit Facility, Lender [Domain] Date of incorporation Entity Incorporation, Date of Incorporation License Agreement and Clinical Research Organization License agreement and clinical research organization Marketable Securities, Noncurrent Marketable securities - long term Entity Tax Identification Number 2022 Notes Twenty Twenty Two Notes [Member] Twenty Twenty Two Notes Member. Class B Third Tranche [Member] Class b third tranche. Class B Third Tranche Conversion and exchange of redeemable convertible preferred stock into common shares in connection with the Reverse Recapitalization (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Derivative Instrument [Axis] Equity Component [Domain] Entity Address, City or Town Unaudited Interim Financial Information and Basis of Presentation Unaudited Interim Financial Information and Basis of Presentation [Policy Text Block] Unaudited interim financial information and basis of presentation. Measurement Input Type [Domain] Long-Term Debt, Maturity, Year One 2026 Principal payments due in next twelve months Stock Issued During Period, Value, New Issues Tranche Three Tranche Three [Member] Tranche three. Percentage of price per share Percentage Of Price Per Share Percentage of price per share. Investments, Fair Value Disclosure Investments, Fair Value Disclosure, Total Marketable securities Clinical Operations [Member] Clinical Operations. Clinical Operations Entity Common Stock, Shares Outstanding Schedule of Carrying Value of Term Loan Schedule of Debt [Table Text Block] Marketable Securities [Table Text Block] Schedule of Marketable Securities Long-Term Debt [Member] Long-term Investments Summary Of Components Of The Provision For Income Taxes Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Summary of Cash Paid for Amounts Included in Measurement of Operating Lease Liabilities [Table Text Block] Summary of cash paid for amounts included in measurement of operating lease liabilities. Summary of Cash Paid for Amounts Included in the Measurement of the Operating Lease Liabilities Initial maturity term Debt Instrument Initial Maturity Term Debt instrument initial maturity term. Segment Reporting, Expense Information Used by CODM, Description Antidilutive Security, Excluded EPS Calculation [Table] Denominator: Weighted Average Number of Shares Outstanding, Diluted [Abstract] June Twenty Twenty Six Performance-Based Equity Retention Awards [Member] June twenty twenty six performance-based equity retention awards. June 2026 Performance-Based Equity Retention Awards Payments to Acquire Marketable Securities Purchases of marketable securities Purchases of marketable securities Statement [Table] Realized gains or losses on sale or maturity of available-for-sale securities Debt Securities, Available-for-Sale, Realized Gain (Loss) Debt Securities, Available-for-Sale, Realized Gain (Loss), Total Total operating lease cost Lease, Cost Total share-based compensation expense Share-Based Payment Arrangement, Expense Stock-based compensation expense Net loss before provision for income taxes Net loss before provision for income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Net loss before income taxes Class B Second Tranche Class B Second Tranche [Member] Class b second tranche. Entity Shell Company Expected term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Net cash used in investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Statement [Line Items] Software, Internally Developed [Member] Computer Software Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Net Derivative Asset (Liability), Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Maximum Maximum [Member] Maximum [Member] Initial maturity date Debt Instrument Initial Maturity Date Debt instrument initial maturity date. Temporary equity no par value Temporary Equity No Par Value Temporary equity no par value. Quoted market price of public warrants Quoted Market Price of Public Warrants Quoted market price of public warrants. Debt Disclosure [Abstract] Sale of Stock [Domain] Temporary equity shares issued Temporary Equity, Shares Issued Tranche 2 Advance Subject to Achievement of Specified Interim Milestone Tranche Two Advance Subject to Achievement of Specified Interim Milestone [Member] Tranche two advance subject to achievement of specified interim milestone. Interest income Interest income Investment Income, Interest Tranche 2 to Tranche 3 Tranche Two to Tranche Three [Member] Tranche two to tranche three . Exchange ratio Reverse Recapitalization Exchange Ratio Reverse recapitalization exchange ratio. Subsequent Events [Abstract] Share-based compensation expense APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition Asset Class [Axis] Summary Of Net Deferred Income Tax Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Investments, Debt and Equity Securities [Abstract] Phase I Clinical Trial [Member] Phase I Clinical Trial Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Granted Share Based Compensation Arrangement By Share Based Payment Award, Options, Grants In Period Related to Performance Based Retention Awards Share based compensation arrangement by share based payment award, options, grants In period related to performance based retention awards. Granted - performance-based retention options (June 2026) Restructuring Cost and Reserve [Line Items] Current assets: Assets, Current [Abstract] Debt Issuance Costs, Net, Total Debt issuance costs Debt Issuance Costs, Net Professional fees Accrued Professional Fees, Current Period within loan disbursements to be made Period Within Loan Disbursements to be Made Period within loan disbursements to be made. Marketable Securities [Line Items] Leases [Abstract] Convertible debentures Convertible Debt, Noncurrent Document Fiscal Year Focus Payments for Restructuring Amounts paid or otherwise settled during the period Advance Subject to Achievement of Specified Approval Milestone Advance Subject To Achievement Of Specified Approval Milestone [Member] Advance subject to the achievement of the specified Approval Milestone. Warrants, maturity period Warrants And Rights Outstanding Maturity Period Warrants and rights outstanding maturity period. Accretion (Amortization) of Discounts and Premiums, Investments Accretion of marketable securities Accretion of marketable securities Common stock shares outstanding Common Stock, Shares, Outstanding, Beginning Balance Common Stock, Shares, Outstanding, Ending Balance Common Stock, Shares, Outstanding Total Common Shares outstanding immediately after the Reverse Recapitalization and PIPE Financing Prime Rate Prime Rate [Member] Unrestricted Cash Unrestricted Cash Unrestricted cash Restructuring Type [Axis] Preferred Share Warrants Preferred Share Warrants [Member] Preferred share warrants. Aggregate amount of base rental payments Aggregate Amount Of Base Rental Payments Aggregate amount of base rental payments. Open Market Sale Agreement Open Market Sale Agreement [Member] Open Market Sale Agreement. Financial Instruments [Domain] Summary of Outstanding Principal, Accrued Interest and Unamortized Deferred Financing Costs of Convertible Debentures Recorded on Balance Sheet Entity Ex Transition Period Payment to NTC upon assigning the License Agreement Payment On Assigning License to Third Party Payment on assigning license to third party Tranche Four [Member] Tranche four. Tranche Four Performance-based restricted share units awards issued Performance-based Restricted Share Units Awards Issued Performance-based restricted share units awards issued. Operating lease liabilities, net of current portion Operating Lease, Liability, Noncurrent Warrants to Purchase Redeemable Convertible Preferred Shares Warrants to purchase redeemable convertible preferred shares Warrants to Purchase Redeemable Convertible Preferred Shares [Member] Warrants to purchase redeemable convertible preferred shares. Additional lease commitments to be paid Lessee, Operating Lease, Liability, to be Paid Total Other Other Accrued Liabilities, Current Additional paid-in capital Additional Paid in Capital, Common Stock Security Exchange Name Measurement Input Type [Axis] Total Convertible debentures Convertible Debt, Total Convertible debt Convertible Debt New Accounting Pronouncements, Policy [Policy Text Block] Recently Adopted Accounting Pronouncements Acquirer [Axis] Acquirer. Warrants to purchase common shares Warrant Liabilities Warrants, each exercisable for one Common share, at an exercise price of $11.50 per share Warrants, exercise price per share Class of Warrant or Right, Exercise Price of Warrants or Rights Non-cash lease expense Non Cash Lease Expenses Non cash lease expenses. Entity Address, State or Province Unrecognized compensation expense weighted-average period of recognition Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition FEAC FEAC [Member] FEAC. FEAC Expected volatility, Minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Number of shares authorized increased Evergreen provision. Evergreen Provision Evergreen Provision [Member] Performance-Based Cash Retention Awards [Member] Performance-Based Cash Retention Awards Member. Performance-Based Cash Retention Awards Operating Lease, Right-of-Use Asset Operating lease right of use asset Operating lease right of use assets Cash Equivalents and Short-term Investments [Member] Cash equivalents and short-term investments. Cash Equivalents and Short Term Investments Amendment Amendment Flag Convertible Debentures Convertible Debentures DisclosureTextBlock Convertible Debentures. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Right of use assets obtained in exchange for lease liabilities Share-Based Compensation Share-Based Payment Arrangement [Text Block] Common Shares Issued to Pipe Investors Common Shares Issued to Pipe Investors [Member] Common shares issued to pipe investors. Interest Expense, Debt, Total Interest expense Interest Expense, Debt Non qualified stock option. Non Qualified Stock Option [Member] Nonqualified Stock Options Debt Instrument [Axis] Total other (income) expense, net Other Nonoperating Income (Expense) Other expense (income), net Other expenses (income), net Other expenses, net Tranche 1 Advance Tranche One Advance [Member] Tranche one advance. May 2023 Financing May Twenty Twenty Three Financing [Member] May Twenty Twenty Three Financing Member. CEO Transition Agreement. CEO Transition Agreement [Member] CEO Transition Agreement City Area Code Share-Based Compensation Arrangement by Share-Based Payment Award, Options Vested Share-based compensation arrangement by share-based payment award, options vested. Shares vested Interest expense Interest Expense, Nonoperating Interest Expense, Nonoperating, Total Entity Listings [Table] Organization, Consolidation and Presentation of Financial Statements [Abstract] Proceeds from Issuance of Common Stock Aggregate gross proceeds of common stock Research and Development Expense [Abstract] Research and development expenses: Incentive options to purchase common shares awarded pursuant to the 2023 Plan Incentive Options To Purchase Common Shares Awarded Pursuant to Two Thousand and Twenty Three Plan [Member] Incentive options to purchase common shares awarded pursuant to two thousand and twenty three plan. Share-Based Compensation Arrangement by Share-Based Payment Award, Options Granted Share-based compensation arrangement by share-based payment award, options granted. Stock options granted The Old Plans The Old Plans [Member] The old plans. Restricted Share Units Awarded Pursuant To Two Thousand and Twenty Three Plan [Member] Restricted Share Units Awarded Pursuant To Two Thousand and Twenty Three Plan [Member] Restricted share units awarded pursuant to the 2023 Plan Operating expenses: Operating Expenses [Abstract] Computer Equipment Computer Equipment [Member] Fair value of common shares and exercise price of options, Maximum Share Based Compensation Arrangement By Share Based Payment Award Fair Value of Common Shares and Exercise Price of Options Maximum Share based compensation arrangement by share based payment award fair value of common shares and exercise price of options maximum. Hercules Warrants Hercules Warrants [Member] Hercules warrants. Change in fair value of convertible debentures embedded derivative liabilities Change in fair value of convertible debentures embedded derivative liabilities Change In Fair Value Of Convertible Debentures Embedded Derivative Liabilities Change in fair value of convertible debentures embedded derivative liabilities. Expenses related to the annual maintenance fee Annual Maintenance Fee Under License Agreement Annual maintenance fee under license agreement Earnings Per Share [Table] Earnings Per Share Total current liabilities Total current liabilities Liabilities, Current US Government Corporations and Agencies Securities [Member] Government Agency Securities Leasehold Improvements Leasehold Improvements [Member] Property, Plant and Equipment, Gross, Total Property and equipment Property, Plant and Equipment, Gross, Beginning Balance Property, Plant and Equipment, Gross, Ending Balance Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration] Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Warrants to purchase shares of common stock Warrants To Purchase Shares Of Common Stock Warrants to purchase shares of common stock. Chemistry Manufacturing and Controls [Member] Chemistry Manufacturing and Controls. Chemistry, Manufacturing and Controls Variable operating lease cost Variable Lease, Cost Segment Reporting [Text Block] Segment Reporting Two Thousand Twenty Six Term Loan [Member] Two Thousand Twenty Six Term Loan 2026 Term Loan Unrealized foreign currency losses Unrealized foreign currency transaction losses Unrealized Gain (Loss), Foreign Currency Transaction, before Tax Unrealized foreign currency losses (gains) Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Long-Term Debt, Maturity, Year Four 2029 Amended and Restated Employment Agreement [Member] Amended and restated employment agreement. A&R Sweiti Employment Agreement Loan amortization date Loan Amortization Date Loan amortization date. Trading Symbol Geographical [Axis] Summary of Property and Equipment Property, Plant, and Equipment [Table Text Block] Subsequent Event [Table] Debt instrument, interest rate Interest rate Debt Instrument, Interest Rate During Period Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Granted Entity Emerging Growth Company Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Table] Additional Paid in Capital Additional Paid-in Capital [Member] Hercules Capital Hercules Capital [Member] Hercules capital. Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions Number of unrealized loss position for greater than 12 months Percentage Of Unrealized Loss On Security Percentage Of Unrealized Loss On Security. Percentage of unrealized loss on security Acquirer [Domain] Acquirer. Fair value of common shares and exercise price of options, Minimum Share Based Compensation Arrangement By Share Based Payment Award Fair Value of Common Shares and Exercise Price of Options Minimum Share based compensation arrangement by share based payment award fair value of common shares and exercise price of options minimum. Note payable, including End of Term Charge Long-Term Debt, Gross Plan Name [Domain] Share-Based Compensation Arrangement by Share-Based Payment Award, Options Forfeited Share-based compensation arrangement by share-based payment award, options forfeited. Shares forfeited Loan and Security Agreement Loan and Security Agreements [Member] Loan and security agreements. Temporary equity shares authorized unlimited Temporary Equity Shares Authorized Unlimited Temporary equity shares authorized unlimited. Fair Value of Common Share Measurement Input, Conversion Price [Member] Fair value of common share at conversion of listing event Share Based Compensation Arrangements by Share Based Payment Award, Options, Grants In Period Related to Performance Based Retention Awards, Weighted Average Exercise Price Share based compensation arrangements by share based payment award, options, grants In period related to performance based retention awards, weighted average exercise price. Weighted-Average Exercise Price, Granted - performance-based retention options (June 2026) US Treasury Securities [Member] US Treasury U.S. Government Treasuries Advance on loan allocated to warrants. Advance on Loan Allocated to Warrants. Advance on loan allocated to warrants Less transaction costs previously deferred and netted against proceeds Transactions costs deferred and netted against proceeds Transactions Costs Deferred and Netted Against Proceeds Transactions costs deferred and netted against proceeds. Less transaction costs previously deferred and netted against proceeds Cover Cover [Abstract] Other segment items Segment Reporting, Other Segment Item, Amount Income Tax Contingency [Table] Percentage of total commitment amount Percentage Of Commitment Amount Percentage of commitment amount. 2021 Loan and Security Agreement 2021 Loan and Security Agreement [Member] 2021 loan and security agreement. Assumptions Used to Determine Fair Value of Liabilities Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Non-cash interest expense Non-cash Interest Expense Non-cash interest expense. Marketable Securities [Table] Restructuring and Related Cost, Estimated Percentage of Workforce Reduction Restructuring and related cost, estimated percentage of workforce reduction. Percentage of workforce reduction estimated Warrant term Warrant Term Warrant term. Accumulated Other Comprehensive Income (Loss), Net of Tax, Total Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Share-Based Payment Arrangement, Noncash Expense, Total Share-based compensation expense Share-Based Payment Arrangement, Noncash Expense Non-cash stock-based compensation expense recognized upon vesting New Laboratory and Office Space New Laboratory and Office Space [Member] New laboratory and office space. Adjustments to reconcile net loss to net cash used in operating activities Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Fair Value Disclosures [Abstract] Cash and Cash Equivalents, at Carrying Value, Total Cash and cash equivalents Cash and Cash Equivalent Stock Based Compensation [Member] Stock based compensation. Stock Based Compensation Payments of Debt Issuance Costs Payment of issuance costs associated with Second Amended Term Loan Non-cash Stock-based Compensation Expense, Recognized Upon Vesting For Milestone Non-cash stock-based compensation expense, recognized upon vesting for milestone. Non-cash stock-based compensation expense, recognized upon vesting for milestone Initial maturity period Debt Instrument Initial Maturity Period Debt instrument initial maturity period. Series 2 Class C Redeemable Convertible Preferred Series 2 Class C Redeemable Convertible Preferred [Member] Series 2 class c redeemable convertible preferred. 2025 Employee Stock Purchase Plan [Member] Employee Stock [Member] Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Term loan facility, drawn term Line of Credit Facility, Drawn Term Line of credit facility, drawn term. Upfront Fees Upfront fee Upfront Fees Payables and Accruals [Abstract] Net loss attributable to common shareholders, basic Net loss attributable to common shareholders, basic Net loss attributable to common stockholders, basic Net loss attributable to common stockholders, basic Net Income (Loss) Available to Common Stockholders, Basic Percentage of aggregate principle amount of term loan advances amount fee Percentage of Aggregate Pricipal Amount of Term Loan Advances Amount Fee Percentage of aggregate principle amount of term loan advances amount fee. Entity Filer Category Debt Instrument, Name [Domain] Marketable securities - short term Marketable Securities, Current Weighted-Average Exercise Price, Options vested and exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Expected Milestone Expense Expected milestone expense. Expected milestone expense Conversion ratio Preferred Stock, Convertible, Conversion Ratio Restructuring and Related Cost, Number of Positions Eliminated, Period Percent Percentage of workforce reduction Numerator: Net Income (Loss) Available to Common Stockholders, Basic [Abstract] Adjustments to Additional Paid in Capital, Warrant Issued Issuance of warrants in connection with Amended Term Loan expense Issuance of warrants Property and equipment, net Property and equipment, net Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization Beginning balance (in shares) Ending balance (in shares) Shares, Outstanding Segment Reporting [Abstract] Summary Of Reconciliation Of Company's Statutory Income Tax Rate Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Entity Address, Postal Zip Code Change in fair value of convertible debenture embedded derivative liabilities Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Earnings Statement of Financial Position [Abstract] Local Phone Number